Do biomarkers allow a differentiation between osteonecrosis of the femoral head and osteoarthritis of the hip? – a biochemical, histological and gene expression analysis. Issue 11 (November 2021)

• Record Type: Journal Article
• Authors: Floerkemeier, T.; Budde, S.; Willbold, E.; Schwarze, M.; Niehof, M.; Lichtinghagen, R.; Windhagen, H.; Weizbauer, A.; Reifenrath, J.
• Is Part Of: Osteoarthritis and cartilage. Volume 29:Issue 11(2021)
• Page Start: 1614
• Page End: 1623
• Publication Date: 2021-11
• Subjects: Degenerative hip diseases -- Gene expression analysis -- Asporin -- Adiponectin -- HIF 1α -- Oxidative stress; Osteoarthritis -- Periodicals; Cartilage -- Periodicals; Osteoarthritis -- Periodicals; Cartilage -- Periodicals; Arthrose -- Périodiques; Articulations -- Maladies -- Périodiques; 616.7223005
• DOI: 10.1016/j.joca.2021.08.006
• Languages: English
• ISSNs: 1063-4584

Abstract

Summary: Objective: Osteonecrosis of the femoral head (ONFH) is a devastating disease of the hip joint. Its early diagnosis is crucial to increase the chances of joint preserving, yet difficult due to similarities with osteoarthritis (OA) of the hip in its clinical appearance. The purpose of this study was to enhance the understanding of ONFH and its pathologic processes in contrast to OA and to identify serum biomarkers helping to improve the diagnosis of the disease. Design: Bone and bone marrow samples were collected from 24 patients diagnosed with OA and 25 patients with ONFH during total hip replacement surgery. RNA was isolated, histological examination, determination of free reactive oxygen species as well as gene expression and biomarker analysis were performed. Results: Histological analysis revealed differences in the structural and cellular pattern between the groups. Gene expression analysis revealed a significant upregulation for the genes ASPN, COL1A1, COL2A1 and IL6 and a significant downregulation for HIF1A in ONFH compared to OA group. Analysis of serum biomarkers showed significant differences between the groups for asporin and adiponectin. A final logistical regression model including the parameters adiponectin, asporin and HIF 1α was overall significant, explained 34.5 % of variance and classified 74.5 % of the cases correctly. Conclusion: The combination of adiponectin, asporin and HIF 1α as serum biomarkers revealed a classification accuracy of 74.5 %. The information provided in this study may help to enhance the understanding of pathologic processes in ONFH and to elaborate further aspects of prediction and treatment.